A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation
- 1 July 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (1) , 152-159
- https://doi.org/10.1182/blood-2005-09-3866
Abstract
Normal erythropoiesis critically depends on the balance between the renewal of precursor cells and their differentiation. If the renewal phase is shortened, the decrease in the precursor pool results in anemia; conversely, impaired differentiation increases the number of proliferating progenitors and the potential risk of leukemic transformation. Using gene ablation, we have discovered 2 self-sustaining signal transduction loops that antagonize each other and regulate erythroid progenitor proliferation and differentiation, respectively. We identify Raf-1 as the main activator of the MEK/ERK cascade and as the key molecule in maintaining progenitor proliferation. Differentiation, in contrast, is mediated by Fas via the activation of both the ASK1/JNK/p38 module and the caspase cascade. The point of convergence between the 2 cascades is activated ERK, which positively feeds back on the proliferation pathway by maintaining the expression of Raf-1, while inhibiting the expression of Fas and therefore differentiation. In turn, Fas, once expressed, antagonizes proliferation by exerting a negative feedback on ERK activation and Raf-1 expression. Simultaneously, Fas-mediated caspase activation precipitates differentiation. These results identify Raf-1 and Fas as the key molecules whose expression finely tunes erythropoiesis and the extent of ERK activation as the switch that tips the balance between them. (Blood. 2006;108:152-159)Keywords
This publication has 41 references indexed in Scilit:
- MicroRNAs: a developing storyCurrent Opinion in Genetics & Development, 2005
- Apoptotic mechanisms in the control of erythropoiesisLeukemia, 2004
- Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutantsOncogene, 2003
- Epigenetic changes in tumor Fas levels determine immune escape and response to therapyCancer Cell, 2002
- Apoptosis Protection by the Epo Target Bcl-XL Allows Factor-Independent Differentiation of Primary ErythroblastsCurrent Biology, 2002
- Inhibition of MEK Induces Fas Expression and Apoptosis in Lymphomas Overexpressing RasLeukemia & Lymphoma, 2002
- Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transductionBritish Journal of Haematology, 1999
- The Raf‐1 Protein Mediates Insulin‐Like Growth Factor‐Induced Proliferation of Erythroid Progenitor CellsThe International Journal of Cell Cloning, 1998
- RETRACTED: The Fas/Fas Ligand Pathway and Bcl-2 Regulate T Cell Responses to Model Self and Foreign AntigensImmunity, 1998
- Childhood Acute Lymphoblastic Leukaemia and Aplastic AnaemiaLeukemia & Lymphoma, 1994